Analyst · Cellyan Biotechnology Co., Ltd (HKPD) | Ratings, Price Targets & Consensus

Ratings

Updated Aug 16, 2026

Overall Rating

C+

DCF Score5.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.41

DCF Value+90.28%

$0.78

Potential upside vs current price

Current Stock Price

$0.41

DCF Value+90.28%

$0.78

Potential upside vs current price

Ratings

Updated Aug 16, 2026

Overall Rating

C+

DCF Score5.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$0.41

DCF Value+90.28%

$0.78

Potential upside vs current price

Current Stock Price

$0.41

DCF Value+90.28%

$0.78

Potential upside vs current price